Perspective: A multicenter, randomized, double-blind, active-controlled study to evaluate the effects of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction Jan 1, 2017 - Dec 31, 2019
A clinical trial of LCZ verses valsartan in heart failure patients with preserved ejection fraction. The study uses MRI and PET scans to identify amyloid deposits in the brain and any adverse effects of cognitive function of teh study drug, LCZ696.Read More

IRONMAN: Effectiveness of Intravenous iron treatment vs standard care in patients with heart failure and iron deficiency: a randomised, open-label multicentre trial May 5, 2017 - Apr 30, 2022
A BHF funded study to compare the effect of additional intravenous iron IV therapy versus standard therapy for patients with chronic heart failure and left ventricular systolic dysfunction and iron deficiency.
Recruitment is 12 patients per ye... Read More

Galactic-HF: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction Apr 1, 2017 - Jul 31, 2021
Acronym is derived from : Global approach to lowering adverse cardiac outcomes through improving contractility in heart failure.
A phase III randomised placebo controlled clinical trial sponsored by Amgen Inc of omecamtiv mercabil, a study dru... Read More

Does glycated hemoglobin variability in type 2 diabetes differ depending on the diabetes treatment used in the Qatari population: implication on diabetes complication risk Aug 1, 2016 - Jul 31, 2020

SilHF: Sildenafil in Heart Failure Mar 3, 2014 - Jun 22, 2018

Commander: A randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of Rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary ar Oct 1, 2015 - May 31, 2018

A multi-centre, randomized, double-blind, placebo-controlled phase II study to assess the effect of Serelaxin versus placebo on high-sensitivity cardia troponin I (hs-cTnl) release in patients with chronic heart failure after exercise when used in additio Feb 18, 2016 - Feb 17, 2017

Respond CRT-D Jan 10, 2013 - Feb 8, 2017

Development Costs: A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects Oct 5, 2015 - Oct 4, 2017

BreatheMOR: Morphine for the relief of breathlessness in stable chronic heart failure Oct 1, 2013 - Feb 28, 2019
Opioids have been used for centuries to relieve pain and other symptoms. A meta-analysis in 2002 of eight randomised controlled trials (RCTs) showed that opioids had a clinically relevant beneficial effect on dyspnoea in people with mainly chronic ob... Read More

AFFERENT14: A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects Oct 5, 2015 - Jul 31, 2018

AFFERENT12: AF219-012: A 12 week Study to assess the Efficacy and tolerability of AF 219 in subjects with treatm Mar 1, 2016 - May 31, 2018

PARAGON: A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection Apr 1, 2015 - Mar 31, 2020

Cardiogoniometry Studies Apr 1, 2016 - Dec 31, 2017

INcrease Of VAgal TonE in chronic Heart Failure. A pivotal trial to establish the long-term safety & efficacy of the cardiofit system May 7, 2014 - Sep 6, 2019

α-synuclein is a key novel regulator of platelet function. Jan 1, 2020 - Dec 31, 2022
Non-Clinical PhD Studentship

SOLOIST: A Randomized, Double-Blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Effects of SOtagliLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST worsening Heart Failure. Aug 1, 2018 - Jan 31, 2021
A Randomized, Double-Blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Effects of SOtagliLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST worsening Heart Failure.

AZD9977: A Phase I, Open Label, Randomized, Parallel group, Multicentre study to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium [sK+] during 28 days in Patients with HFmrEF or HFpEF and eGFR in the range of ≥40 and ≤70 mL/min/1.73m2 Feb 1, 2019 - Jan 31, 2020
A Phase I, Open Label, Randomized, Parallel group, Multicentre study to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium [sK+] during 28 days in Patients with HFmrEF or HFpEF
and eGFR in the range of ≥40 and ≤70 mL/min/1.73m...

Comparing Outcomes of Through knee and Above knee Amputation Apr 17, 2019 - Dec 31, 2021